<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T02:15:07Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/185168" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/185168</identifier><datestamp>2025-12-05T14:25:52Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478816</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Endoplasmic reticulum stress downregulates PGC-1α in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2</dc:title>
   <dc:creator>Montori Grau, Marta</dc:creator>
   <dc:creator>Aguilar, David</dc:creator>
   <dc:creator>Zarei, Mohammad</dc:creator>
   <dc:creator>Pizarro Delgado, Javier</dc:creator>
   <dc:creator>Palomer Tarridas, Francesc Xavier</dc:creator>
   <dc:creator>Vázquez Carrera, Manuel</dc:creator>
   <dc:subject>Reticle endoplasmàtic</dc:subject>
   <dc:subject>Diabetis</dc:subject>
   <dc:subject>Resistència a la insulina</dc:subject>
   <dc:subject>Endoplasmic reticulum</dc:subject>
   <dc:subject>Diabetes</dc:subject>
   <dc:subject>Insulin resistance</dc:subject>
   <dc:description>Background Peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) downregulation in skeletal muscle contributes to insulin resistance and type 2 diabetes mellitus. Here, we examined the effects of endoplasmic reticulum (ER) stress on PGC-1α levels in muscle and the potential mechanisms involved. Methods The human skeletal muscle cell line LHCN-M2 and mice exposed to different inducers of ER stress were used. Results Palmitate- or tunicamycin-induced ER stress resulted in PGC-1α downregulation and enhanced expression of activating transcription factor 4 (ATF4) in human myotubes and mouse skeletal muscle. Overexpression of ATF4 decreased basal PCG-1α expression, whereas ATF4 knockdown abrogated the reduction of PCG-1α caused by tunicamycin in myotubes. ER stress induction also activated mammalian target of rapamycin (mTOR) in myotubes and reduced the nuclear levels of cAMP response element-binding protein (CREB)-regulated transcription co-activator 2 (CRTC2), a positive modulator of PGC-1α transcription. The mTOR inhibitor torin 1 restored PCG-1α and CRTC2 protein levels. Moreover, siRNA against S6 kinase, an mTORC1 downstream target, prevented the reduction in the expression of CRTC2 and PGC-1α caused by the ER stressor tunicamycin. Conclusions Collectively, these findings demonstrate that ATF4 and the mTOR-CRTC2 axis regulates PGC-1α transcription under ER stress conditions in skeletal muscle, suggesting that its inhibition might be a therapeutic target for insulin resistant states.</dc:description>
   <dc:date>2022-04-28T12:28:35Z</dc:date>
   <dc:date>2022-04-28T12:28:35Z</dc:date>
   <dc:date>2022-04-15</dc:date>
   <dc:date>2022-04-28T12:28:36Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>1478-811X</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/185168</dc:identifier>
   <dc:identifier>723069</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1186/s12964-022-00865-9</dc:relation>
   <dc:relation>Cell Communication and Signaling, 2022, vol. 20, p. 53</dc:relation>
   <dc:relation>https://doi.org/10.1186/s12964-022-00865-9</dc:relation>
   <dc:rights>cc-by (c) Montori Grau, Marta et al., 2022</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>BioMed Central</dc:publisher>
   <dc:source>Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>